AL
Alumis Inc. Common Stock (ALMS)
NASDAQ·Healthcare·Biotechnology
$24.07
-2.75%
Mkt Cap $3.07B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $2.36M | $1.93M | -18.36% | -$0.97 | -$0.95 | +2.06% | — | — |
| Q4 2025 Nov 13, 2025 | $2.75M | $2.07M | -24.87% | -$0.92 | -$1.06 | -15.22% | — | — |
| Q3 2025 Aug 13, 2025 | $3.14M | $2.67M | -15.17% | -$1.11 | -$1.17 | -5.41% | — | — |
| Q2 2025 May 14, 2025 | $1.67M | $17.39M | +943.34% | -$1.47 | -$1.82 | -23.81% | — | — |
| Q1 2025 Mar 19, 2025 | $1.00M | $1.52M | +51.80% | -$1.40 | -$0.23 | +83.57% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$1.64 | -$1.73 | -5.49% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$4.50 | -$23.10 | -413.33% | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.96 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$4.50 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$1.13 | — | — | — |
| Q2 2023 Jun 29, 2023 | — | — | — | — | -$0.70 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.69 | — | — | — |